GALECTIN THERAPEUTICS INC. (GALT) Net income 2016–2025
GALECTIN THERAPEUTICS INC. (GALT) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$30.8MFY2025 · since FY2016: -$21.4M → -$30.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$30.8M | +34.5% |
| FY2024 | -$47.0M | -14.6% |
| FY2023 | -$41.1M | -5.9% |
| FY2022 | -$38.8M | -27.0% |
| FY2021 | -$30.5M | -30.1% |
| FY2020 | -$23.5M | -76.5% |
| FY2019 | -$13.3M | +4.4% |
| FY2018 | -$13.9M | +14.4% |
| FY2017 | -$16.2M | +24.3% |
| FY2016 | -$21.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice